A163 DIRECT ACTING ANTIVIRAL UPTAKE DISPARITIES IN HIV-HEPATITIS C CO-INFECTED POPULATIONS IN CANADA

BACKGROUND: Direct acting antivirals (DAAs) have revolutionized hepatitis C (HCV) treatment with nearly 100% cure rates even in real-world studies, giving hope that HCV can be eliminated. Historically, HCV treatment initiation rates have been low, particularly among people who inject drugs (PWID) an...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Can Assoc Gastroenterol
Auteurs principaux: Saeed, S, Strumpf, E, Walmsley, S, Cooper, C, Conway, B, Laferriere, V, Pick, N, Wong, A, Klein, M B
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Poster Presentations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507735/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.164
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires